{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T03:23:50Z","timestamp":1785295430149,"version":"3.55.0"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,31]],"date-time":"2024-12-31T00:00:00Z","timestamp":1735603200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["UM1 AI106701"],"award-info":[{"award-number":["UM1 AI106701"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["UM1 AI068636"],"award-info":[{"award-number":["UM1 AI068636"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["UM1 AI068634"],"award-info":[{"award-number":["UM1 AI068634"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009633","name":"Eunice Kennedy Shriver National Institute of Child Health and Human Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009633","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","award":["AI068632"],"award-info":[{"award-number":["AI068632"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Chromatography B"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.jchromb.2024.124439","type":"journal-article","created":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:11:02Z","timestamp":1735690262000},"page":"124439","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Development and validation of an LC-MS\/MS method for quantifying total and unbound doravirine in human plasma"],"prefix":"10.1016","volume":"1252","author":[{"given":"Rizqah","family":"Bernard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sydwell P.","family":"Maputla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phiwe","family":"Zuma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anton","family":"Joubert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Castel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marthinus","family":"van der Merwe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edda","family":"Zangenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lubbe","family":"Wiesner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jchromb.2024.124439_b0005","unstructured":"HIVinfo.NIH.gov, HIV Treatment, (2021). https:\/\/hivinfo.nih.gov\/understanding-hiv\/fact-sheets\/hiv-treatment-basics (accessed April 20, 2023)."},{"key":"10.1016\/j.jchromb.2024.124439_b0010","unstructured":"UNAIDS, Fact Sheet 2024, Global HIV Statistics. https:\/\/www.unaids.org\/sites\/default\/files\/media_asset\/UNAIDS_FactSheet_en.pdf (accessed September 29, 2024)."},{"key":"10.1016\/j.jchromb.2024.124439_b0015","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1001\/jama.2016.8900","article-title":"Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults","volume":"316","author":"G\u00fcnthard","year":"2016","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.jchromb.2024.124439_b0020","doi-asserted-by":"crossref","first-page":"e211","DOI":"10.1016\/S2352-3018(18)30021-3","article-title":"DRIVE-FORWARD Study Group, Doravirine Versus Ritonavir-Boosted Darunavir in Antiretroviral-Naive Adults with HIV-1 (DRIVE-FORWARD): 48-Week Results of a Randomised, Double-Blind, Phase 3 Non-Inferiority Trial","volume":"5","author":"Molina","year":"2018","journal-title":"Lancet HIV"},{"key":"10.1016\/j.jchromb.2024.124439_b0025","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1093\/cid\/ciy540","article-title":"Doravirine\/Lamivudine\/Tenofovir Disoproxil Fumarate is Non-inferior to Efavirenz\/Emtricitabine\/Tenofovir Disoproxil Fumarate in Treatment-naive Adults With Human Immunodeficiency Virus\u20131 Infection: Week 48 Results of the DRIVE-AHEAD Trial","volume":"68","author":"Orkin","year":"2019","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.jchromb.2024.124439_b0030","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1097\/FTD.0b013e3181817318","article-title":"Determination of Unbound Antiretroviral Drug Concentrations by a Modified Ultrafiltration Method Reveals High Variability in the Free Fraction","volume":"30","author":"Fayet","year":"2008","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.jchromb.2024.124439_b0035","doi-asserted-by":"crossref","unstructured":"M.J. Cervelli, G.R. Russ, Principles of Drug Therapy, Dosing, and Prescribing in Chronic Kidney Disease and Renal Replacement Therapy, in: J. Floege, R.J. Johnson, J. Feehally (Eds.), Comprehensive Clinical Nephrology, Elsevier, 2010, pp. 871\u2013893. Doi: 10.1016\/B978-0-323-05876-6.00073-3.","DOI":"10.1016\/B978-0-323-05876-6.00073-3"},{"key":"10.1016\/j.jchromb.2024.124439_b0040","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1128\/CMR.00092-12","article-title":"Importance of Relating Efficacy Measures to Unbound Drug Concentrations for Anti-Infective Agents","volume":"26","author":"Gonzalez","year":"2013","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.jchromb.2024.124439_b0045","first-page":"23","article-title":"The Metabolic Profiles of HIV-Infected and Non-Infected Women in Mangaung, South Africa","volume":"22","author":"Hattingh","year":"2009","journal-title":"S Afr. J. Clin. Nutr."},{"key":"10.1016\/j.jchromb.2024.124439_b0050","first-page":"74","article-title":"Human Serum Protein and C-Reactive Protein Levels among HIV Infected Subjects in Uromi and its Environs in Edo Nigeria","volume":"5","author":"Ugwu","year":"2016","journal-title":"IJBAIR"},{"key":"10.1016\/j.jchromb.2024.124439_b0055","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.4155\/bio-2019-0116","article-title":"Determination of Doravirine in Human Plasma Using Liquid\u2013Liquid Extraction and HPLC\u2013MS\/MS","volume":"11","author":"Desai","year":"2019","journal-title":"Bioanalysis"},{"key":"10.1016\/j.jchromb.2024.124439_b0060","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1093\/cid\/ciac410","article-title":"Doravirine Concentrations and Human Immunodeficiency Virus Type 1 RNA in the Genital Fluids of Virologically Suppressed Adults Switching to Doravirine Plus Emtricitabine\/Tenofovir Alafenamide","volume":"75","author":"Sc\u00e9vola","year":"2022","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.jchromb.2024.124439_b0065","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1093\/cid\/ciab835","article-title":"Total and Unbound Doravirine Concentrations and Viral Suppression in CSF","volume":"74","author":"Tiraboschi","year":"2022","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.jchromb.2024.124439_b0070","doi-asserted-by":"crossref","first-page":"e4506","DOI":"10.1002\/jms.4506","article-title":"Development and Validation of a Multiplex UHPLC-MS\/MS Assay with Stable Isotopic Internal Standards for the Monitoring of the Plasma Concentrations of the Antiretroviral Drugs Bictegravir, Cabotegravir, Doravirine, and Rilpivirine in People Living with HIV","volume":"55","author":"Courlet","year":"2020","journal-title":"J. Mass Spectrom."},{"key":"10.1016\/j.jchromb.2024.124439_b0075","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1080\/00498254.2018.1451667","article-title":"Characterisation of the Absorption, Distribution, Metabolism, Excretion and Mass Balance of Doravirine, a Non-Nucleoside Reverse Transcriptase Inhibitor in Humans","volume":"49","author":"Sanchez","year":"2019","journal-title":"Xenobiotica"},{"key":"10.1016\/j.jchromb.2024.124439_b0080","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1002\/jcph.1747","article-title":"Physiologically Based Pharmacokinetic Modeling of Doravirine and Its Major Metabolite to Support Dose Adjustment With Rifabutin","volume":"61","author":"Yee","year":"2021","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.jchromb.2024.124439_b0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2022.115010","article-title":"Validation of an LC-MS\/MS Assay for the Simultaneous Determination of Bictegravir Doravirine, and Raltegravir in Human Plasma","volume":"220","author":"Schauer","year":"2022","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jchromb.2024.124439_b0090","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1002\/cpdd.699","article-title":"Evaluation of the Pharmacokinetic Interaction Between Doravirine and Methadone","volume":"9","author":"Khalilieh","year":"2020","journal-title":"Clin. Pharmacol. Drug Dev."},{"key":"10.1016\/j.jchromb.2024.124439_b0095","unstructured":"National Library of Medicine, ClinicalTrials.gov, (2023). https:\/\/clinicaltrials.gov\/study\/NCT05924438 (accessed September 20, 2024)."},{"key":"10.1016\/j.jchromb.2024.124439_b0100","unstructured":"Pifeltro\u00ae [package insert]. Rahway (NJ): Merck & Co., Inc.; 2023. https:\/\/www.merck.com\/product\/usa\/pi_circulars\/p\/pifeltro\/pifeltro_pi.pdf (accessed May 19, 2023)."},{"key":"10.1016\/j.jchromb.2024.124439_b0105","unstructured":"Food and Drug Administration, Bioanalytical Method Validation: Guidance for Industry, (2018). https:\/\/www.fda.gov\/files\/drugs\/published\/Bioanalytical-Method-Validation-Guidance-for-Industry.pdf (accessed January 23, 2024)."},{"key":"10.1016\/j.jchromb.2024.124439_b0110","unstructured":"European Medicines Agency, Guideline on Bioanalytical Method Validation, (2011). https:\/\/www.ema.europa.eu\/en\/documents\/scientific-guideline\/guideline-bioanalytical-method-validation_en.pdf (accessed January 23, 2024)."},{"key":"10.1016\/j.jchromb.2024.124439_b0115","unstructured":"International Council for Harmonization of Technical Requirements for Pharmaceuticals for Human Use, ICH Harmonized Guideline, Bioanalytical Method Validation M10, (2022). https:\/\/database.ich.org\/sites\/default\/files\/M10_Guideline_Step4_2022_0524.pdf (accessed December 10, 2024)."},{"key":"10.1016\/j.jchromb.2024.124439_b0120","doi-asserted-by":"crossref","first-page":"3019","DOI":"10.1021\/ac020361s","article-title":"Strategies for the Assessment of Matrix Effect in Quantitative Bioanalytical Methods Based on HPLC\u2212MS\/MS","volume":"75","author":"Matuszewski","year":"2003","journal-title":"Anal. Chem."},{"key":"10.1016\/j.jchromb.2024.124439_b0125","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.jchromb.2005.11.009","article-title":"Standard Line Slopes as a Measure of a Relative Matrix Effect in Quantitative HPLC\u2013MS Bioanalysis","volume":"830","author":"Matuszewski","year":"2006","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.jchromb.2024.124439_b0130","unstructured":"Sigma-Aldrich, Method Development & Optimization, in: Analytical HPLC, 2024, pp. 136\u2013151. https:\/\/www.sigmaaldrich.com\/deepweb\/assets\/sigmaaldrich\/marketing\/global\/documents\/201\/658\/dicas-de-desenvolvimento-de-metodo-e-otimizacoes.pdf (accessed April 10, 2024)."},{"key":"10.1016\/j.jchromb.2024.124439_b0135","doi-asserted-by":"crossref","unstructured":"T. de Boer, H. Meijering, Equilibrium Dialysis, Ultracentrifugation, and Ultrafiltration in LC-MS Bioanalysis, in: W. Li, W. Jian, Y. Fu (Eds.), Sample Preparation in LC-MS Bioanalysis, John Wiley & Sons, Inc., New Jersey, 2019, pp. 45\u201351. Doi: 10.1002\/9781119274315.CH3.","DOI":"10.1002\/9781119274315.ch3"}],"container-title":["Journal of Chromatography B"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1570023224004483?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1570023224004483?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,23]],"date-time":"2025-02-23T10:30:44Z","timestamp":1740306644000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1570023224004483"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":27,"alternative-id":["S1570023224004483"],"URL":"https:\/\/doi.org\/10.1016\/j.jchromb.2024.124439","relation":{},"ISSN":["1570-0232"],"issn-type":[{"value":"1570-0232","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development and validation of an LC-MS\/MS method for quantifying total and unbound doravirine in human plasma","name":"articletitle","label":"Article Title"},{"value":"Journal of Chromatography B","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jchromb.2024.124439","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"124439"}}